Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3373-3389.e16
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
International consensus statement on microbiome testing in clinical practice
Serena Porcari, Benjamin H. Mullish, Francesco Asnicar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 10, Iss. 2, pp. 154-167
Closed Access | Times Cited: 8
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
Jianzhou Chen, Antonin Lévy, Ai-Ling Tian, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 361-379.e10
Open Access | Times Cited: 1
State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus
Julie Rodriguez, Zahra Hassani, Carolina Alves Costa Silva, et al.
The Lancet Microbe (2024), pp. 100948-100948
Open Access | Times Cited: 7
Long-distance microbial mechanisms impacting cancer immunosurveillance
Laurence Zitvogel, Marine Fidelle, Guido Kroemer
Immunity (2024) Vol. 57, Iss. 9, pp. 2013-2029
Closed Access | Times Cited: 6
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 6
Akkermansia in the gastrointestinal tract as a modifier of human health
María E. Panzetta, Raphael H. Valdivia
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
Friends close, enemies closer: the complex role of the microbiome in antitumor immunity
Dipyaman Patra, Gagan Dev, Timothy W. Hand, et al.
Current Opinion in Immunology (2025) Vol. 93, pp. 102537-102537
Open Access
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R. Cottrell, Michael T. Lotze, Alaa M. Ali, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010928-e010928
Open Access
Hallmarks of artificial intelligence contributions to precision oncology
Tiangen Chang, Seongyong Park, Alejandro A. Schäffer, et al.
Nature Cancer (2025)
Closed Access
Programmed Cell Death Ligand as a Biomarker for Response to Immunotherapy: Contribution of Mass Spectrometry-Based Analysis
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
Cancers (2025) Vol. 17, Iss. 6, pp. 1001-1001
Open Access
Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes
Carolina Alves Costa Silva, Andrew A. Almonte, Laurence Zitvogel
Biomolecules (2025) Vol. 15, Iss. 4, pp. 504-504
Open Access
Two competing guilds as barometers of host health
Huimin Ma, Kai Wang, Changtao Jiang
Science China Life Sciences (2025)
Closed Access
Innovative, early-phase clinical trials of drug–radiotherapy combinations
Antonin Lévy, Christophe Massard, Stefan Michiels, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 4, pp. e190-e202
Closed Access
Unlocking the power of the microbiome for successful cancer immunotherapy
Maria Alejandra Clavijo-Salomon, Giorgio Trinchieri
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011281-e011281
Open Access
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Microbiome testing in clinical practice – Authors' reply
Serena Porcari, Gianluca Ianiro
˜The œLancet. Gastroenterology & hepatology (2025) Vol. 10, Iss. 5, pp. 414-415
Closed Access
Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors
Khoudia Diop, Babacar Mbaye, Somayeh Nili, et al.
Gut Pathogens (2025) Vol. 17, Iss. 1
Open Access
Impact of the ONCOBIOME network in cancer microbiome research
Laurence Zitvogel, Lisa Derosa, Bertrand Routy, et al.
Nature Medicine (2025)
Closed Access
The danger theory of immunity revisited
Guido Kroemer, Léa Montégut, Oliver Kepp, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 912-928
Closed Access | Times Cited: 4
Microbiome testing in Europe: navigating analytical, ethical and regulatory challenges
Julie Rodriguez, Magali Cordaillat-Simmons, Nelly Badalato, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
Mi Young Lim, Seungpyo Hong, Young‐Do Nam
Frontiers in Immunology (2025) Vol. 15
Open Access
Crosstalk between gut microbiota and cancer immunotherapy: present investigations and future perspective
Yuhui Tang, Qiaoting Cai, Zhi Tian, et al.
Research (2025) Vol. 8
Open Access
What Is the Role of Fecal Microbiota Transplantation in Immunotherapy Trials? Current Perspectives and Future Directions
Edmond Rafie, Miguel Zugman, Sumanta K. Pal, et al.
European Urology Focus (2025)
Closed Access
Page 1 - Next Page

Scroll to top